IMRAB 1

Company: Boehringer Ingelheim Animal Health

Rabies 1 Year

Dogs & Cats

10 mL

Rabies Vaccine

Killed Virus

For use in animals only. Restricted to use by or under the direction of a veterinarian.

IMRAB 1 Indications

This product has been shown to be effective for the vaccination of healthy dogs and cats 12 weeks of age and older against rabies virus. The duration of immunity is at least 1 year. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Description

Imrab^® 1 contains the same virus strain that is used in the Pasteur Merieux Connaught human vaccine. The virus is grown in a stable cell line, inactivated, and mixed with a safe and potent adjuvant. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible animals.

Directions and dosage: Shake well before use. Aseptically inject 1 mL (1 dose) subcutaneously into healthy dogs or cats. Revaccinate annually with a single 1 mL dose.

Precautions

Store at 2-8°C (35-46°F). Do not freeze. Do not use chemicals to sterilize syringes and needles. Do not mix with other products. Use entire contents when first opened. Contains gentamicin and thimerosal as preservatives. This product has not been tested in pregnant animals. A transient local reaction may occur at the injection site following subcutaneous administration. Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection site fibrosarcomas. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. In case of human exposure, contact a physician.

Imrab^® is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.

Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601

Phone: 1 (888) 637-4251

VLN/PCN 124/1905.25

CPN: 1028352.0